nach oben

Die Dermatologie

Erschienen in:

01.06.2010 | Leitthema

Dermatoendokrinologie

Hautalterung

verfasst von: Dr. E. Makrantonaki, C.C. Zouboulis

Erschienen in: Die Dermatologie | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Zusammenfassung

Hormone und deren Inbalancen haben signifikante Auswirkungen auf die Morphologie und die Physiologie der Haut und beeinflussen verschiedene Hautfunktionen, u. a. die Wundheilung und die Lipogenese. Mit zunehmendem Alter nimmt die Konzentration von wichtigen zirkulierenden Hormonen, darunter Wachstumsfaktoren und Sexualsteroide, kontinuierlich ab. Infolgedessen werden physiologische Prozesse der Haut negativ beeinflusst, und es kann zur Entwicklung verschiedener alterungsassoziierter Erkrankungen kommen. Das Verständnis derartiger fundamentaler Zusammenhänge wird im Hinblick auf die Verschiebung der Alterspyramide, bei Erhöhung der Anzahl der über 80-jährigen Menschen größte Bedeutung erlangen und ist ebenfalls bei der Krankheitsprävention entscheidend.

Makrantonaki E, Zouboulis CC (2007) The skin as a mirror of the aging process in the human organism – state of the art and results of the aging research in the German National Genome Research Network 2 (NGFN-2). Exp Gerontol 42:879–886CrossRefPubMed

Makrantonaki E, Zouboulis CC (2007) William J. Cunliffe Scientific Awards. Characteristics and pathomechanisms of endogenously aged skin. Dermatology 214:352–360CrossRefPubMed

Miller KK (2001) Androgen deficiency in women. J Clin Endocrinol Metab 86:2395–2401CrossRefPubMed

Roshan S, Nader S, Orlander P (1999) Review: Ageing and hormones. Eur J Clin Invest 29:210–213CrossRefPubMed

Yen SS, Laughlin GA (1998) Aging and the adrenal cortex. Exp Gerontol 33:897–910CrossRefPubMed

Tenover JL (1997) Testosterone and the aging male. J Androl 18:103–106PubMed

Simon D, Preziosi P, Barrett-Connor E et al (1992) The influence of aging on plasma sex hormones in men: the Telecom Study. Am J Epidemiol 135:783–791PubMed

Gray A, Feldman HA, McKinlay JB, Longcope C (1991) Age, disease and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab 73:1016–1025CrossRefPubMed

Russell-Aulet M, Dimaraki EV, Jaffe CA et al (2001) Aging-related growth hormone (GH) decrease is a selective hypothalamic GH-releasing hormone pulse amplitude mediated phenomenon. J Gerontol A Biol Sci Med Sci 56:M124–M129PubMed

10.

Corpas E, Harman SM, Blackman MR (1993) Human growth hormone and human aging. Endocr Rev 14:20–39PubMed

11.

Zouboulis CC (2000) Human skin: an independent peripheral endocrine organ. Horm Res 54:230–242CrossRefPubMed

12.

Zouboulis CC, Chen WC, Thornton MJ et al (2007) Sexual hormones in human skin. Horm Metab Res 39:85–95CrossRefPubMed

13.

Reichrath J, Lehmann B, Carlberg C et al (2007) Vitamins as hormones. Horm Metab Res 39:71–84CrossRefPubMed

14.

Carroll PV, Christ ER, Bengtsson BA et al (1998) Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab 83:382–395CrossRefPubMed

15.

Laron Z (2005) Do deficiencies in growth hormone and insulin-like growth factor-1 (IGF-1) shorten or prolong longevity? Mech Ageing Dev 126:305–307CrossRefPubMed

16.

Tomlinson JW, Holden N, Hills RK et al (2001) Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 357:425–431CrossRefPubMed

17.

Lewis DA, Travers JB, Somani AK, Spandau DF (2010) The IGF-1/IGF-1R signaling axis in the skin: a new role for the dermis in aging-associated skin cancer. Oncogene 29(10):1475–1485CrossRefPubMed

18.

Affinito P, Palomba S, Sorrentino C et al (1999) Effects of postmenopausal hypoestrogenism on skin collagen. Maturitas 33:239–247CrossRefPubMed

19.

Callens A, Vaillant L, Lecomte P et al (1996) Does hormonal skin aging exist? A study of the influence of different hormone therapy regimens on the skin of postmenopausal women using non-invasive measurement techniques. Dermatology 193:289–294CrossRefPubMed

20.

Fuchs KO, Solis O, Tapawan R, Paranjpe J (2003) The effects of an estrogen and glycolic acid cream on the facial skin of postmenopausal women: a randomized histologic study. Cutis 71:481–488PubMed

21.

Maheux R, Naud F, Rioux M et al (1994) A randomized, double-blind, placebo-controlled study on the effect of conjugated estrogens on skin thickness. Am J Obstet Gynecol 170:642–649PubMed

22.

Raine-Fenning NJ, Brincat MP, Muscat-Baron Y (2003) Skin aging and menopause: implications for treatment. Am J Clin Dermatol 4:371–378CrossRefPubMed

23.

Schmidt JB, Binder M, Demschik G et al (1996) Treatment of skin aging with topical estrogens. Int J Dermatol 35:669–674CrossRefPubMed

24.

Rudman D, Feller AG, Nagraj HS et al (1990) Effects of human growth hormone in men over 60 years old. N Engl J Med 323:1–6PubMedCrossRef

25.

Azzi L, El-Alfy M, Martel C, Labrie F (2005) Gender differences in mouse skin morphology and specific effects of sex steroids and dehydroepiandrosterone. J Invest Dermatol 124:22–27CrossRefPubMed

26.

Seidenari S, Pagnoni A, Di Nardo A, Giannetti A (1994) Echographic evaluation with image analysis of normal skin: variations according to age and sex. Skin Pharmacol 7:201–209CrossRefPubMed

27.

Sjostrom L, Smith U, Krotkiewski M, Bjorntorp P (1972) Cellularity in different regions of adipose tissue in young men and women. Metabolism 21:1143–1153CrossRefPubMed

28.

Lee KS, Oh KY, Kim BC (2000) Effects of dehydroepiandrosterone on collagen and collagenase gene expression by skin fibroblasts in culture. J Dermatol Sci 23:103–110CrossRefPubMed

29.

Shin MH, Rhie GE, Park CH et al (2005) Modulation of collagen metabolism by the topical application of dehydroepiandrosterone to human skin. J Invest Dermatol 124:315–323CrossRefPubMed

30.

Baulieu EE, Thomas G, Legrain S et al (2000) Dehydroepiandrosterone (DHEA), DHEA sulfate and aging: contribution of the DHEAge Study to a sociobiomedical issue. Proc Natl Acad Sci U S A 97:4279–4284CrossRefPubMed

31.

Bolognia JL (1995) Aging skin. Am J Med 98:99S–103SCrossRefPubMed

32.

Punnonen R (1972) Effect of castration and peroral estrogen therapy on the skin. Acta Obstet Gynecol Scand Suppl 21:3–44PubMed

33.

Bennett AE, Wahner HW, Riggs BL, Hintz RL (1984) Insulin-like growth factors I and II: aging and bone density in women. J Clin Endocrinol Metab 59:701–704CrossRefPubMed

34.

Ikawa A, Ishii Y, Suzuki K et al (2002) Age-related changes in the dorsal skin histology in Mini and Wistar rats. Histol Histopathol 17:419–426PubMed

35.

Elias PM, Ghadially R (2002) The aged epidermal permeability barrier: basis for functional abnormalities. Clin Geriatr Med 18:103–120, viiCrossRefPubMed

36.

Ye J, Garg A, Calhoun C et al (2002) Alterations in cytokine regulation in aged epidermis: implications for permeability barrier homeostasis and inflammation. I. IL-1 gene family. Exp Dermatol 11:209–216CrossRefPubMed

37.

Tsutsumi M, Denda M (2007) Paradoxical effects of beta-estradiol on epidermal permeability barrier homeostasis. Br J Dermatol 157:776–779CrossRefPubMed

38.

Ashcroft GS, Horan MA, Ferguson MW (1997) The effects of ageing on wound healing: immunolocalisation of growth factors and their receptors in a murine incisional model. J Anat 190(Pt 3):351–365CrossRefPubMed

39.

Ashcroft GS, Ashworth JJ (2003) Potential role of estrogens in wound healing. Am J Clin Dermatol 4:737–743CrossRefPubMed

40.

Gilliver SC, Ashcroft GS (2007) Sex steroids and cutaneous wound healing: the contrasting influences of estrogens and androgens. Climacteric 10:276–288CrossRefPubMed

41.

Hardman MJ, Emmerson E, Campbell L, Ashcroft GS (2008) Selective estrogen receptor modulators accelerate cutaneous wound healing in ovariectomised female mice. Endocrinology 149(2):551–557CrossRefPubMed

42.

Gilliver SC, Ruckshanthi JP, Atkinson SJ, Ashcroft GS (2007) Androgens influence expression of matrix proteins and proteolytic factors during cutaneous wound healing. Lab Invest 87:871–881CrossRefPubMed

43.

Ashcroft GS, Mills SJ, Flanders KC et al (2003) Role of Smad3 in the hormonal modulation of in vivo wound healing responses. Wound Repair Regen 11:468–473CrossRefPubMed

44.

Zouboulis CC, Boschnakow A (2001) Chronological ageing and photoageing of the human sebaceous gland. Clin Exp Dermatol 26:600–607CrossRefPubMed

45.

Pochi PE, Strauss JS, Downing DT (1979) Age-related changes in sebaceous gland activity. J Invest Dermatol 73:108–111CrossRefPubMed

46.

Engelke M, Jensen JM, Ekanayake-Mudiyanselage S, Proksch E (1997) Effects of xerosis and ageing on epidermal proliferation and differentiation. Br J Dermatol 137:219–225CrossRefPubMed

47.

Dunn LB, Damesyn M, Moore AA et al (1997) Does estrogen prevent skin aging? Results from the First National Health and Nutrition Examination Survey (NHANES I). Arch Dermatol 133:339–342CrossRefPubMed

48.

Makrantonaki E, Adjaye J, Herwig R et al (2006) Age-specific hormonal decline is accompanied by transcriptional changes in human sebocytes in vitro. Aging Cell 5:331–344CrossRefPubMed

49.

Makrantonaki E, Vogel K, Fimmel S et al (2008) Interplay of IGF-I and 17beta-estradiol at age-specific levels in human sebocytes and fibroblasts in vitro. Exp Gerontol 43:939–946CrossRefPubMed

50.

Akamatsu H, Zouboulis CC, Orfanos CE (1992) Control of human sebocyte proliferation in vitro by testosterone and 5-alpha-dihydrotestosterone is dependent on the localization of the sebaceous glands. J Invest Dermatol 99:509–511CrossRefPubMed

51.

Zouboulis CC, Seltmann H, Neitzel H, Orfanos CE (1999) Establishment and characterization of an immortalized human sebaceous gland cell line (SZ95). J Invest Dermatol 113:1011–1020CrossRefPubMed

52.

Rosenfield RL, Deplewski D, Kentsis A, Ciletti N (1998) Mechanisms of androgen induction of sebocyte differentiation. Dermatology 196:43–46CrossRefPubMed

53.

Chen W, Yang CC, Sheu HM et al (2003) Expression of peroxisome proliferator-activated receptor and CCAAT/enhancer binding protein transcription factors in cultured human sebocytes. J Invest Dermatol 121:441–447CrossRefPubMed

54.

Zouboulis CC, Eady A, Philpott M et al (2005) What is the pathogenesis of acne? Exp Dermatol 14:143–152CrossRefPubMed

55.

Makrantonaki E, Zouboulis CC (2007) Testosterone metabolism to 5alpha-dihydrotestosterone and synthesis of sebaceous lipids is regulated by the peroxisome proliferator-activated receptor ligand linoleic acid in human sebocytes. Br J Dermatol 156:428–432CrossRefPubMed

56.

Kramer C, Seltmann H, Seifert M et al (2009) Characterization of the vitamin D endocrine system in human sebocytes in vitro. J Steroid Biochem Mol Biol 113:9–16CrossRefPubMed

57.

Sato T, Imai N, Akimoto N et al (2001) Epidermal growth factor and 1alpha,25-dihydroxyvitamin D3 suppress lipogenesis in hamster sebaceous gland cells in vitro. J Invest Dermatol 117:965–970CrossRefPubMed

58.

Ghadially R, Brown BE, Hanley K et al (1996) Decreased epidermal lipid synthesis accounts for altered barrier function in aged mice. J Invest Dermatol 106:1064–1069CrossRefPubMed

59.

Fernandez-Tresguerres Hernandez JA (2004) Effects of hormones on aging of the CNS, the immune system and the skin in rats. An R Acad Nac Med (Madr) 121:157–176; discussion 176–159

60.

Sator PG, Sator MO, Schmidt JB et al (2007) A prospective, randomized, double-blind, placebo-controlled study on the influence of a hormone replacement therapy on skin aging in postmenopausal women. Climacteric 10:320–334CrossRefPubMed

61.

Sator PG, Schmidt JB, Sator MO et al (2001) The influence of hormone replacement therapy on skin ageing: a pilot study. Maturitas 39:43–55CrossRefPubMed

62.

Patriarca MT, Goldman KZ, Dos Santos JM et al (2007) Effects of topical estradiol on the facial skin collagen of postmenopausal women under oral hormone therapy: a pilot study. Eur J Obstet Gynecol Reprod Biol 130:202–205CrossRefPubMed

63.

Gold MH, Goldman MP, Biron J (2007) Efficacy of novel skin cream containing mixture of human growth factors and cytokines for skin rejuvenation. J Drugs Dermatol 6:197–201PubMed

64.

Hennessey JV, Chromiak JA, DellaVentura S et al (2001) Growth hormone administration and exercise effects on muscle fiber type and diameter in moderately frail older people. J Am Geriatr Soc 49:852–858CrossRefPubMed

65.

Kann PH (2003) Growth hormone in anti-aging medicine: a critical review. Aging Male 6:257–263CrossRefPubMed

66.

Savine R, Sonksen P (2000) Growth hormone – hormone replacement for the somatopause? Horm Res 53(Suppl 3):37–41CrossRefPubMed

67.

Mauras N, Rini A, Welch S et al (2003) Synergistic effects of testosterone and growth hormone on protein metabolism and body composition in prepubertal boys. Metabolism 52:964–969CrossRefPubMed

68.

Prakasam G, Yeh JK, Chen MM et al (1999) Effects of growth hormone and testosterone on cortical bone formation and bone density in aged orchiectomized rats. Bone 24:491–497CrossRefPubMed

69.

Lissett CA, Shalet SM (2003) The insulin-like growth factor-I generation test: peripheral responsiveness to growth hormone is not decreased with ageing. Clin Endocrinol (Oxf) 58:238–245

70.

Weber MM (2002) Effects of growth hormone on skeletal muscle. Horm Res 58(Suppl 3):43–48CrossRefPubMed

71.

Percheron G, Hogrel JY, Denot-Ledunois S et al (2003) Effect of 1-year oral administration of dehydroepiandrosterone to 60- to 80-year-old individuals on muscle function and cross-sectional area: a double-blind placebo-controlled trial. Arch Intern Med 163:720–727CrossRefPubMed

72.

Genazzani AR, Inglese S, Lombardi I et al (2004) Long-term low-dose dehydroepiandrosterone replacement therapy in aging males with partial androgen deficiency. Aging Male 7:133–143CrossRefPubMed

73.

Fischer T, Bangha E, Elsner P, Kistler GS (1999) Suppression of UV-induced erythema by topical treatment with melatonin. Influence of the application time point. Biol Signals Recept 8:132–135CrossRefPubMed

74.

Fischer TW, Elsner P (2001) The antioxidative potential of melatonin in the skin. Curr Probl Dermatol 29:165–174CrossRefPubMed

75.

Zouboulis CC, Makrantonaki E (2010) Hormonal therapy of intrinsic aging. J Dtsch Dermatol Ges (in press)

76.

Makrantonaki E, Zouboulis CC (2010) Pathomechanisms of endogenously aged skin. In: Farage MA, Miller KW, Maibach HI (Hrsg) Textbook of aging skin. Springer, Berlin Heidelberg New York Tokyo, S 94–99

Titel: Dermatoendokrinologie
Hautalterung
verfasst von: Dr. E. Makrantonaki
C.C. Zouboulis
Publikationsdatum: 01.06.2010
Verlag: Springer-Verlag
Erschienen in: Die Dermatologie / Ausgabe 6/2010
Print ISSN: 2731-7005
Elektronische ISSN: 2731-7013
DOI: https://doi.org/10.1007/s00105-009-1889-8

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Dermatologie

Riesenzellarteriitis: 15% der Patienten sind von okkulter Form betroffen

16.05.2024 Riesenzellarteriitis Nachrichten

In einer retrospektiven Untersuchung haben Forschende aus Belgien und den Niederlanden die okkulte Form der Riesenzellarteriitis genauer unter die Lupe genommen. In puncto Therapie und Rezidivraten stellten sie keinen sehr großen Unterschied zu Erkrankten mit kranialen Symptomen fest.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Isotretinoin: Risiko für schwere Laboranomalien „marginal erhöht“

08.05.2024 Akne Nachrichten

Die Aknetherapie mit Isotretinoin kann einen Anstieg von Leberenzymen und Blutfetten verursachen. Das Risiko für schwere Störungen ist laut einer Forschungsgruppe der Universität Lübeck aber nur marginal erhöht und auf einen engen Zeitraum konzentriert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2010

Einfluss von Partikel aus dem Straßenverkehr auf die extrinsische Hautalterung

Neutrophilenreiches, CD30+ anaplastisches T-Zell-Lymphom in Assoziation mit einer lymphomatoiden Papulose

Plötzliches Größenwachstum vorher indolenter Knoten am Capillitium

Ausschreibung Detlef-Petzoldt-Preis

Die Talgdrüse